Hematology
University of Utah Study Identifies Mechanism Behind Blood Clot Risk in IBD Patients
New research from the University of Utah reveals why inflammatory bowel disease patients face elevated blood clot risks and suggests potential dual-treatment approaches that could address both clotting and inflammation.
CLL Society Honors Innovators in Leukemia and Lymphoma Research
The CLL Society has awarded three researchers for their innovative projects aimed at improving care and outcomes for patients with chronic lymphocytic leukemia and small lymphocytic lymphoma, highlighting the importance of integrative medicine, clinical research, and overcoming treatment resistance.
GeoVax to Showcase Positive Immune Response Data for GEO-CM04S1 in CLL Patients at EHA 2025 Congress
GeoVax Labs, Inc. will present clinical data at the European Hematology Association 2025 Congress, demonstrating the superior cellular immune response of its GEO-CM04S1 vaccine in chronic lymphocytic leukemia patients compared to mRNA-based vaccines.